UBS Raises Sarepta Therapeutics Price Target on Promising Label Forecast
Friday, 1 March 2024, 11:16
UBS Raises Sarepta Therapeutics Shares Target
UBS has recently increased the price target for Sarepta Therapeutics shares, citing a promising label outlook. This adjustment could have a notable impact on the market as investors reassess their positions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.